Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
XLO on Nasdaq
Christopher James Frankenfield - trading volume in the past year for Xilio Therapeutics, Inc.
Holdings reported by Christopher James Frankenfield for Xilio Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
58.1K |
$57.2K |
$0.98 |
Jan 1, 2025 |
Direct |
Common Stock |
|
| Common stock |
12.4K |
$12.2K |
$0.98 |
Jan 2, 2025 |
Direct |
|
|
| Stock Option (right to buy) |
251K |
|
|
Jan 1, 2025 |
Direct |
Common Stock |
|
Transactions reported by Christopher James Frankenfield for Xilio Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.